J. Goldman & Co LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$307,125
-95.2%
67,500
-93.6%
0.01%
-95.8%
Q1 2023$6,456,217
+673.2%
1,056,664
+5770.4%
0.26%
+521.4%
Q4 2020$835,000
-70.7%
18,000
-81.1%
0.04%
-87.8%
Q1 2020$2,850,00095,2050.34%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders